A retrospective review has revealed that eczema can be associated with a 63% increased chance of patients also developing either...

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis.

Dupilumab-induced ocular surface disease appears to occur more frequently in patients with AD than with other skin conditions.

A research letter published in the Journal of the American Academy of Dermatology has outlined the degree to which symptoms of atopic...

Adult patients with moderate-to-severe AD being treated with dupilumab had lower rates of hospitalization and shorter stays.

A recent meta-analysis has suggested a link between AD and delinquent behaviours in children and adolescents in the US.

Higher doses of upadacitinib show added benefits for adults with moderate-to-severe AD when compared to dupilumab, according to a new study.

Individuals with skin diseases including atopic dermatitis (AD), psoriasis, vitiligo and chronic urticaria (CU) are not at elevated risk...